Fig. 10
FAM162A, MCT1, and COX20 protein expression levels in human adult DCM and ICM heart failure patients. (a) Immunoblot analysis of FAM162A, MCT1, and COX20 in human adult DCM and ICM patient samples. Right panel, densitometric quantification of the blots. Significantly higher levels of FAM162A in human adult DCM and ICM patients, and significantly reduced levels of MCT1 and COX20 protein expression in ICM patients were measured. (b) Immunoblot analysis of FAM162A, MCT1, and COX20 in region-specific infarcted hearts. Right panel, densitometric quantification of the blots. All immunoblots shown are representative of at least 3 total immunoblots performed, n = 3 independent biological replicates. Original uncropped immunoblots are provided in Supplemental Fig. 9. Asterisks indicate a statistically significant p value in a Tukey’s multiple comparison analysis where *p < 0.05 and **p < 0.01; data are presented as mean ± SEM. All source data input and analyzed output files were uploaded to figshare (https://doi.org/10.6084/m9.figshare.11844972.v12).
